| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |